Pérez, E.; Acosta, J.; Pisabarro, V.; Cordani, M.; dos Santos, J.C.S.; Sanz-Landaluze, J.; Gallo, J.; Bañobre-López, M.; Fernández-Lucas, J.
Novel Directed Enzyme Prodrug Therapy for Cancer Treatment Based on 2′-Deoxyribosyltransferase-Conjugated Magnetic Nanoparticles. Biomolecules 2024, 14, 894.
https://doi.org/10.3390/biom14080894
AMA Style
Pérez E, Acosta J, Pisabarro V, Cordani M, dos Santos JCS, Sanz-Landaluze J, Gallo J, Bañobre-López M, Fernández-Lucas J.
Novel Directed Enzyme Prodrug Therapy for Cancer Treatment Based on 2′-Deoxyribosyltransferase-Conjugated Magnetic Nanoparticles. Biomolecules. 2024; 14(8):894.
https://doi.org/10.3390/biom14080894
Chicago/Turabian Style
Pérez, Elena, Javier Acosta, Victor Pisabarro, Marco Cordani, José C. S. dos Santos, Jon Sanz-Landaluze, Juan Gallo, Manuel Bañobre-López, and Jesús Fernández-Lucas.
2024. "Novel Directed Enzyme Prodrug Therapy for Cancer Treatment Based on 2′-Deoxyribosyltransferase-Conjugated Magnetic Nanoparticles" Biomolecules 14, no. 8: 894.
https://doi.org/10.3390/biom14080894
APA Style
Pérez, E., Acosta, J., Pisabarro, V., Cordani, M., dos Santos, J. C. S., Sanz-Landaluze, J., Gallo, J., Bañobre-López, M., & Fernández-Lucas, J.
(2024). Novel Directed Enzyme Prodrug Therapy for Cancer Treatment Based on 2′-Deoxyribosyltransferase-Conjugated Magnetic Nanoparticles. Biomolecules, 14(8), 894.
https://doi.org/10.3390/biom14080894
